The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
March 8th 2024
A survey of more than 1500 people revealed misconceptions about living with diabetes, particularly regarding the efficacy of GLP-1 weight loss drugs as a standalone solution for managing their health goals.
In her keynote address Anne Peters, MD, CDE, Director, Clinical Diabetes Program, University of Southern California, opened the meeting by defining what patient-centered care is. Providing care that is respectful of and responsive to individual patient preferences, needs, values, and ensuring that patients are involved in all clinical decisions, said Dr. Peters. She emphasizes the importance of looking to the needs of the individual patient and make decisions.
Read More
Previously Unrecognized Trends in Diabetes Consumption Clusters in Medicare
Medicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.
Read More
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Read More
Ronald J. Sigal, MD, MPH, a professor of medicine, cardiac sciences, kinesiology, and community health sciences at the University of Calgary in Canada, and a Health Senior Scholar at the Alberta Heritage Foundation for Medical Research, pulls from his experience to discuss the reality of the current expectations and goals for exercise and physical activity in the overweight or obese patient with diabetes, and offers his solutions.
Watch
Philip R. Schauer, MD, the director of the Bariatric and Metabolic Institute (BMI) at the Cleveland Clinic in Ohio contends that accountable care organizations (ACOs) need to recognize obesity as a legitimate disease that is the basis for many other serious conditions. He emphasizes that obesity certainly requires treatment, and surgery is an appropriate intervention for certain patients.
Watch
Diabetes Coaching Services in the Pharmacy Setting
June 24th 2013Carl Dean Benton, RPh, explains how pharmacists can contribute to improvements in patient care through counseling programs. With the provisions of the Affordable Care Act, many insurers may begin to recognize the benefits of pharmacist-driven counseling initiatives, and integrate these programs to help improve outcomes for patients with type 2 diabetes.
Read More
Todd Brusko, PhD, Remarks on Evolving Role of Immunoregulation in Type 1 Diabetes
June 24th 2013Todd Brusko, PhD, of the Todd M. Brusko Laboratory at the University of Florida College of Medicine, discussed how knowledge of regulatory T-cells has grown and improved, and noted that research has now entered a phase of harnessing the potential of our immune system through specific cell populations to combat root causes of type 1 diabetes (T1DM).
Watch
Novel SGLT-2 Inhibitors: The Impact on Outcomes in Diabetes and Cardiovascular Health
June 23rd 2013Bernard Zinman, MD, the director of the Leadership Sinai Centre for Diabetes and the Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital and the University of Toronto in Canada, discusses the new therapies, SGLT-2 inhibitors, that are now approved in the United States and European Union. These drug therapies have shown clinical benefits in both type 1 and type 2 diabetes, and may also improve cardiovascular outcomes for patients with type 2 diabetes
Read More
Connecting the Dots: Global Epidemiology of Type 1 Diabetes and National Income Levels
June 23rd 2013Jaakko Tuomilehto, MD, PhD, a professor of public health at the University of Helsinki in Finland provides global epidemiological data for T1DM and discusses the World Health Organization's Diabetes Mondiale (DiaMond) study. He compares the rates of incidences of T1DM among well-developed, high-income countries to low- and middle-income nations and takes note of the epidemiological trends.
Read More
In light of ongoing healthcare reform in the US, Sheldon Greenfield, MD, the executive co-director of the Health Policy Research Institute and Donald Bren Professor of Medicine at the University of California Irvine School of Medicine, shared his insights on the role of quality care measures in the management of diabetes, and weighed in on the advantages and disadvantages associated with implementing these tools.
Watch
Rita Basu, MD, Discusses The Role of Testosterone Supplementation in Men with Diabetes
June 23rd 2013Accounting for what is known about the association between diabetes and low testosterone in men, Rita Basu, MD, a professor of medicine at the Mayo Clinic in Rochester, MN provides her insights on the role of testosterone supplementation in men with diabetes, and notes how clinical and managed care perspectives are integrated in practice.
Watch
Diabetes Cost-Effectiveness Studies and How They Affect Real-World Treatment
June 22nd 2013Cost-effectiveness analyses (CEAs) have real effects on therapeutic approaches for patients with type 2 diabetes mellitus (T2DM). Dr. Gilmer discusses how studies like the United Kingdom Prospective Diabetes Study (UKPDS) and the Diabetes Prevention Program (DPP) have affected how researchers and scientists evaluate the benefits of new treatments.
Read More